MOH · NYSE · STOCK
Molina Healthcare (MOH) Stock Analysis
$197.00
52W $121.06 – $244.89
51/100
$10.28B
—
0.78
Is MOH Bullish or Bearish?
Mixed.
Innellis AI committee rates Molina Healthcare, Inc. (MOH) Watch with a composite score of 51/100
, based on 6 analysts with 33% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +9.44 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -10.56 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.23 across 13 articles, 14d). Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- News sentiment is positive (+0.23 across 13 articles, 14d) — News
Bear Case
- ROE of only -0.2% -- cheap may mean cheap for a reason — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Bollinger bandwidth of 15.6% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
51/100
Agreement
33%
Analysts
6
Conviction
Contested
Sector Rank
Top 91%
of 192 Healthcare peers
Value Analyst
neutral
42
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− ROE of only -0.2% -- cheap may mean cheap for a reason
Growth Analyst
bearish
38
/ 100 · Moderate confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 15.6% signals elevated volatility
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
65
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.23 across 13 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 50.6 to 50.6.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Risk Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
58.5
Neutral
MACD Histogram
0.868
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$186.95
Resistance
$200.12
Bollinger %B
0.55
Inside Bands
Price vs Moving Averages
EMA 9
$193.85
Above
EMA 21
$194.87
Above
EMA 50
$197.84
Below
EMA 200
$193.51
Above
Fundamental Analysis
Valuation
62
Growth
39
Profitability
22
Financial Health
75
Cash Flow
70
Valuation
P/E Ratio
—
P/B Ratio
2.42×
PEG Ratio
-12.41
Dividend Yield
0.00%
52W High
$244.89
52W Low
$121.06
Quality & Growth
ROE
1160.0%
ROA
303.3%
Gross Margin
803.9%
Operating Margin
45.6%
Revenue Growth YoY
—
Debt / Equity
0.95
AI Fundamental Assessment
P/E ratio of 1230.8 (rich relative to a 15-40x range); Price-to-book of 2.4x; PEG ratio of -12.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 11.6%; Return on assets of 3.0%; Net margin of -0.0%; Gross margin of 8.0%; Current ratio of 1.68 (healthy short-term liquidity); Debt-to-equity of 0.95; Free cash flow per share is positive (5.28); Most recent quarter beat estimates by 7.5%; 2 consecutive earnings beats; EPS growth decelerating (+185.5% -> -35.7% QoQ); Analyst estimates rising over recent quarters
Get the Full MOH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →